Celldex Therapeutics Prices Public Offering of 7.425M Common Shares At $27/Share
Portfolio Pulse from Benzinga Newsdesk
Celldex Therapeutics has priced its public offering of 7.425 million common shares at $27 per share.
November 08, 2023 | 7:51 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Celldex Therapeutics has announced a public offering of 7.425 million shares at $27 each. This could potentially dilute existing shares, impacting the stock price.
Public offerings often lead to dilution of existing shares, which can put downward pressure on the stock price. As such, the announcement of this offering could potentially have a negative impact on Celldex Therapeutics' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100